Australian Pharma Stock News

Perenti’s Barminco subsidiary recently secured an underground mining contract with Bellevue Gold valued at about A$850 million, commencing 1 August with an option for a 12‑month extension. This win, alongside the 1 June appointment of Vanessa Torres as managing director and chief executive, underscores Perenti’s focus on expanding higher‑value underground mining services in Australia. We’ll now examine how this sizeable Bellevue Gold contract influences Perenti’s existing investment...

REA Group (ASX:REA) is back in focus after multiple broker downgrades and renewed scrutiny of Australia’s proposed tax changes, with investors weighing the risk of softer listing volumes against the company’s recent A$200 million buyback completion. See our latest analysis for REA Group. At A$143.0, the stock has fallen about 16% on a 30 day share price return basis and is down 22.61% year to date. The 1 year total shareholder return of a 37.67% decline contrasts with a 7.41% gain over three...

CSL has recently cut its FY26 revenue and profit forecasts following earnings downgrades, writedowns and impairments tied to shifts in US immunoglobulin sales channels and softer China albumin prices, ahead of its full-year results and dividend announcement previously scheduled for 18 August 2026. Despite these setbacks, investors appear increasingly focused on CSL’s turnaround prospects and the possibility that future impairments could be more contained than previously feared. We’ll now...

Earlier this month, Wesfarmers announced that its Industrial and Safety businesses, Blackwoods and Workwear Group, will be folded into Bunnings Group from 1 July 2026, aligning complementary customer bases while expecting stronger customer value propositions, incremental sales and cost efficiencies with minimal one-off transition costs. The move also coincides with the planned retirement of Industrial and Safety Managing Director Tim Bult and underscores Wesfarmers’ broader 2026 Strategy Day...

In May 2026, GQG Partners reported a sixth consecutive month of net outflows, with funds under management slipping to US$163.3 billion from US$166.9 billion, as industry scrutiny of active equity strategies persisted. Because GQG’s high, largely unfranked US dollar dividend relies heavily on stable funds under management, these ongoing outflows sharpen investor focus on how secure its income engine really is. We’ll now examine how this pattern of net outflows, against a backdrop of a high...

Develop Global recently approved final investment decisions for its Sulphur Springs copper-zinc and Pioneer Dome lithium projects, underpinned by a US$400 million funding package from Trafigura that includes a US$350 million loan facility, a US$50 million warrant package and binding offtake agreements. This combination of project commitments, long-term offtake and structured financing marks a major step in Develop Global’s shift toward being a multi-commodity producer with both mining...

Ramelius Resources (ASX:RMS) has been in focus after its share price reacted to weaker gold prices and the company reaffirmed its FY26 production guidance midpoint while lifting all in sustaining cost estimates. See our latest analysis for Ramelius Resources. At around A$3.01, Ramelius has seen its share price fall 15.9% over the past 30 days and 28.8% year to date, even though its 3 year total shareholder return is very large. This suggests recent share price momentum has cooled despite...

If you are wondering whether Lynas Rare Earths at around A$17.77 still offers value, the key is to understand what the current share price actually builds in. The stock has pulled back recently, with the price declining 2.1% over the past week and 10.7% over the past month, although it is still up 45.4% year to date and 97.4% over the last year. Those moves have kept Lynas Rare Earths firmly on investor watchlists as one of the more closely followed rare earth producers, particularly given...

Guzman y Gomez's index removal puts focus on stock fundamentals Guzman y Gomez (ASX:GYG) is set to be removed from the S&P/ASX 200 index before 22 June 2026 after recent underperformance relative to the broader market and a heavier index tilt toward resource and other priority sectors. The reshuffle is expected to prompt selling by index funds that track the benchmark, which can affect short term trading volumes and liquidity. This places greater emphasis on Guzman y Gomez’s earnings profile...

Earlier this week, Sunrise Energy Metals drew attention as it progressed toward a final investment decision on its Syerston scandium project, supported by a multi‑year scandium oxide supply option with Lockheed Martin. The combination of advancing a critical minerals project timeline and securing interest from a major aerospace and defense contractor has sharpened focus on Sunrise Energy Metals’ role in future scandium supply chains. Next, we’ll examine how the Lockheed Martin supply option...

Goodman Group (ASX:GMG) is back in focus after its shares rose 1.57% despite a recent director share sale, with attention centred on the group’s growing global data centre development pipeline. See our latest analysis for Goodman Group. At A$31.52, the stock’s recent 2.24% 1 day share price return and strong 22.6% 90 day share price return suggest momentum has been building, even though the 1 year total shareholder return is down 6.38% and the 5 year total shareholder return is 60.19%. If...

Earlier in June 2026, Bank of Queensland reported its first-half FY26 results showing a 20% decline in statutory profit, driven by margin compression, higher costs, and increased credit expenses, while highlighting moderating economic growth and persistent inflation pressures. At the same time, management emphasised a strong capital position that could support a share buyback and special dividend, drawing attention to how capital management may offset operating headwinds. We’ll now examine...

Telix Pharmaceuticals recently reported Part 1 data from its ProstACT Global Phase 3 trial in metastatic castration-resistant prostate cancer, showing TLX591-Tx had an acceptable safety and tolerability profile with no new safety signals when combined with standard-of-care therapies. The findings underline a potentially differentiated safety profile versus existing PSMA-targeted radioligand therapies, with lower kidney and salivary gland exposure that may be clinically meaningful for...

FireFly Metals (ASX:FFM) is set to join the S&P/ASX 200 index from 22 June 2026, a milestone that can draw fresh attention from index funds and broaden the stock’s institutional shareholder base. See our latest analysis for FireFly Metals. At the latest share price of A$1.905, FireFly Metals has had a mixed few months, with the share price down 11% over 30 days but up 9% over 90 days, while the 1 year total shareholder return of 84.95% points to strong longer term momentum that recent index...

The recent price decline of 11% in Pureprofile Ltd's ( ASX:PPL ) stock may have disappointed insiders who bought...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Elevra Lithium has been promoted to the S&P/ASX 200 index following the quarterly rebalance, effective 22 June 2026, marking a new phase after its 2025 merger and rebranding. The company’s expanded footprint across Canada, the United States, Australia and Ghana underscores its growing role in lithium supply for the global energy transition. We’ll examine how Elevra Lithium’s elevation to the S&P/ASX 200 reshapes its investment narrative through greater index-driven visibility and...

Evolution Mining (ASX:EVN) is back in focus after its share price fell alongside a drop in gold prices, even as the company reported a record first half FY26 statutory profit and a fully franked interim dividend. See our latest analysis for Evolution Mining. That profit announcement comes after a choppy period for the stock, with the share price down about 12% over 30 days and 13% over 90 days, even as the 1 year total shareholder return is 31% and the 3 year total shareholder return is very...

Recently, WiseTech Global reported ongoing revenue growth, progress on its AI transformation and e2open integration, and reaffirmed its FY26 revenue and EBITDA guidance, even as the broader ASX tech sector weakened. An important takeaway is that cost synergies from the e2open acquisition are running ahead of schedule, signaling quicker-than-expected efficiency gains across WiseTech’s expanded logistics platform. Next, we’ll examine how WiseTech’s reaffirmed FY26 guidance and faster e2open...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

Potential Peter Warren Automotive Holdings Limited ( ASX:PWR ) shareholders may wish to note that the Independent...

Lendlease Group (ASX:LLC) has drawn fresh attention after appointing Nick O'Neil as Group CEO and Managing Director from September 2026, reaffirming its FY26 earnings per security guidance and outlining a substantial pipeline of secured projects. See our latest analysis for Lendlease Group. The recent leadership update and reaffirmed FY26 guidance come after a mixed period for investors, with a 16.67% 7 day share price return following heavier declines, including a 44.38% year to date share...

Interest in ASX (ASX:ASX) has sharpened as the exchange works through technology modernisation, ongoing scrutiny of the failed CHESS replacement project, and the appointment of ex Euronext executive Anthony Attia as incoming CEO. See our latest analysis for ASX. The 1-day share price return of 0.78% and 7-day share price return of 3.19% sit against a weaker 30-day share price return, down 14.2%, with the 1-year total shareholder return down 29.9%. This indicates pressure on sentiment even as...

BSA Limited ( ASX:BSA ) insiders who bought shares over the past year were rewarded handsomely last week. The stock...